Healthcare - Biotechnology - NASDAQ - GB
$ 31.59
-3.16 %
$ 1.58 B
Market Cap
-34.34
P/E
INCOME STATEMENT
249 M
REVENUE
-59.6 M
OPERATING INCOME
-55.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Immunocore Holdings plc
| Revenue | 249 M |
| Cost Of Revenue | 1.04 M |
| Gross Profit | 248 M |
| Operating Expenses | 308 M |
| Operating Income | -59.6 M |
| Other Expenses | -4.36 M |
| Net Income | -55.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 249.4 | 143.7 | 26.5 | 30.1 | 25.7 | 23.7 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.0 | 0.5 | 73.2 | 74.8 | 100.0 | 0 |
| Gross Profit | 248.4 | 143.3 | (46.7) | (44.7) | (74.3) | 23.7 |
| OPERATING INCOME | ||||||
| Operating Expenses | 308.0 | 182.9 | 161.7 | 119.4 | 144.2 | 117.7 |
| Selling, General and Administrative Expenses | 144.5 | 93.7 | 88.4 | 45.7 | 44.2 | 34.2 |
| Research and Development Expenses | 163.5 | 89.2 | 73.2 | 74.8 | 100.0 | 83.6 |
| Operating Income | (59.6) | (39.6) | (135.2) | (86.2) | (118.3) | (93.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 5.2 | 7.7 | 5.8 | 3.1 | 3.8 | 0.8 |
| Total Other Income | (1.2) | 5.8 | 33.7 | (1.2) | (7.9) | 5.3 |
| Pre-Tax Income | (60.9) | (44.1) | (140.9) | (87.4) | (126.2) | (88.2) |
| NET INCOME | ||||||
| Tax Provision | (5.6) | (2.9) | (9.4) | (13.3) | (22.3) | (16.5) |
| Net Income | (55.3) | (41.2) | (131.5) | (74.1) | (103.9) | (71.6) |
| EPS | 1.13 | 0.9 | 3.1 | 2.33 | 3.81 | 2.62 |